scispace - formally typeset
F

Fernando Remião

Researcher at University of Porto

Publications -  201
Citations -  7109

Fernando Remião is an academic researcher from University of Porto. The author has contributed to research in topics: Oxidative stress & Chemistry. The author has an hindex of 42, co-authored 172 publications receiving 5900 citations. Previous affiliations of Fernando Remião include University of Aveiro & Universidade Nova de Lisboa.

Papers
More filters
Journal ArticleDOI

Paraquat Poisonings: Mechanisms of Lung Toxicity, Clinical Features, and Treatment

TL;DR: The most pertinent and significant findings published in established scientific publications since the discovery of PQ are collected and described, focusing on the most recent developments related to PQ lung toxicity and their relevance to the treatment of human poisonings.
Journal ArticleDOI

Toxicity of amphetamines: an update

TL;DR: The long-studied classical amphetamines—amphetamine itself, as well as methamphetamine and MDMA provide plenty of data that may be useful to predict toxicological outcome to improvident abusers and are for that reason the main focus of this review.
Journal ArticleDOI

Paraquat exposure as an etiological factor of Parkinson's disease.

TL;DR: PQ-induced lipid peroxidation and consequent cell death of dopaminergic neurons can be responsible for the onset of the Parkinsonian syndrome, thus indicating that this herbicide may induce PD or influence its natural course.
Journal ArticleDOI

Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

TL;DR: The main aim of this review was to contribute to the understanding of the cellular and molecular mechanisms involved in MDMA neurotoxicity, which can help in the development of therapeutic approaches to prevent or treat the long-term neuropsychiatric complications of MDMA abuse in humans.
Journal ArticleDOI

Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy

TL;DR: In this review, a new focus is brought on the therapeutic interest of inducing and/or activating P-gp for limiting the toxicity caused by its substrates, and several in vivo and in vitro studies validating the use of such a therapeutic strategy are discussed.